Skip to main content
Premium Trial:

Request an Annual Quote

Aniling Gets CE-IVD Marks for Cancer Sequencing Tests

NEW YORK – Aniling said on Thursday that it has obtained CE-IVD marks for three of its cancer sequencing tests.

The Barcelona, Spain-based diagnostics company said its chronic lymphocytic leukemia, colorectal cancer, and liquid biopsy tests are now compliant with the EU's new In Vitro Diagnostic Directive. Aniling has also implemented a quality management system in line with the ISO:13485 standard.

CEO and Cofounder Llorenç Coll said in a statement that obtaining regulatory compliance for the trio of tests is "an important step to consolidate Aniling's market entry strategy and business project."

The tests are based on the firm's genomic and epigenomic unified sequencing (GEUS) technology, which analyzes genetic and epigenetic biomarkers as part of the same test. The first two assays, called GEUS-CLL and GEUS-CRC, can be used to diagnose, monitor, and select the best therapies for patients with CLL and colon cancer, respectively.

GEUS-LB provides information about tumor DNA that can be used to diagnose a patient via liquid biopsy. The Catalan Institute of Oncology, the Institute for Health Science Research Germans Trias i Pujol (IGTP), Hospital Clinic Barcelona, and Munich Leukemia Laboratory all helped to validate Aniling's tests.

The company is a spinout of IGTP's Institute of Predictive and Personalized Medicine of Cancer. It is currently negotiating a Series A round worth €7 million ($7.1 million) that it expects will aid in the clinical validation of its tests, as well as to expand its product menu.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.